AI English summary of an SEC filing — figures as filed
Elevance Health ELVThe company said shareholders elected Susan D. DeVore, Bahija Jallal and Ryan M. Schneider as directors on May 14, 2025 at its annual meeting, to serve three-year terms expiring at the 2028 annual meeting.
Key points
AI summaryThe company said shareholders elected Susan D. DeVore, Bahija Jallal and Ryan M. Schneider as directors on May 14, 2025 at its annual meeting, to serve three-year terms expiring at the 2028 annual meeting.
Elevance Health said its advisory vote on named executive officer compensation was approved, with 173,964,580 votes for, 15,522,459 against and 238,310 abstentions.
The company said shareholders approved the appointment of Ernst & Young LLP as its independent registered public accounting firm for 2025, with 178,086,607 votes for, 23,455,317 against and 126,128 abstentions.
The company said a shareholder proposal requesting a report on the effectiveness of Diversity, Equity, and Inclusion efforts was not approved, with 26,240,205 votes for, 160,685,853 against and 2,799,291 abstentions.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Three Directors Elected to Serve 3-Year Terms Expiring in 2028
The company said shareholders elected Susan D. DeVore, Bahija Jallal and Ryan M. Schneider as directors on May 14, 2025 at its annual meeting, to serve three-year terms expiring at the 2028 annual meeting.
Source · Based on the filing body and exhibits
Advisory vote on executive pay approved
Elevance Health said its advisory vote on named executive officer compensation was approved, with 173,964,580 votes for, 15,522,459 against and 238,310 abstentions.
Source · Based on the filing body and exhibits
Shareholders approve Ernst & Young LLP as auditor for 2025
The company said shareholders approved the appointment of Ernst & Young LLP as its independent registered public accounting firm for 2025, with 178,086,607 votes for, 23,455,317 against and 126,128 abstentions.
Source · Based on the filing body and exhibits
Shareholder proposal on DEI effectiveness report fails
The company said a shareholder proposal requesting a report on the effectiveness of Diversity, Equity, and Inclusion efforts was not approved, with 26,240,205 votes for, 160,685,853 against and 2,799,291 abstentions.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…